Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
-
A3316 Clemizole hydrochlorideTarget: Histamine H1 Receptors|TRPC channelSummary: H1 histamine receptor antagonist
-
A3317 Clozapine N-oxide (CNO)1 CitationTarget: DREADD LigandsSummary: Metabolite of clozapine, used in chemogenetics.
-
A3401 Etifoxine hydrochlorideTarget: GABAA receptorSummary: GABAA receptor potentiator
-
A3423 Galanthamine2 CitationTarget: AChESummary: Acetylcholinesterase inhibitor
-
A3565 LX-1031Target: Tryptophan hydroxylases (TPH)Summary: TPH inhibitor
-
A3727 Pitolisant hydrochlorideSummary: Nonimidazole inverse agonist
-
A3744 QuetiapineTarget: AChR|adrenergic receptor|5-HT receptor|Dopamine receptor|Histamine receptorSummary: Dopamine receptor antagonist
-
A3811 SEA04004 CitationTarget: Na /Ca2 Exchangers (NCXs)Summary: Specific inhibitor of Na+/Ca2+ exchange
-
A3874 Tiotropium BromideTarget: AChRSummary: MAChR M antagonist
-
A3926 VortioxetineTarget: 5-HT1 Receptors|5-HT7 Receptors|5-HT3 Receptors|SERTSummary: 5-HT receptors antagonist